arXiv:2607. 18696v1 Announce Type: new Abstract: AI-native biotechnology companies are often designed by copying human biotech org charts into agent roles.
arXiv:2606. 09556v1 Announce Type: new Abstract: AI Scientist agents are often evaluated as if capability were mainly a function of model quality, prompting, or reasoning scaffolds.
arXiv:2609.21841v1 Announce Type: new Abstract: Frontier language models now produce professional deliverables that expert graders judge to match human work on a substantial share of economically val...
arXiv:2609.16213v1 Announce Type: new Abstract: Artificial intelligence is reshaping biological research across an increasingly connected digital-to-physical workflow. General-purpose large language...
arXiv:2606. 19899v1 Announce Type: cross Abstract: This paper addresses a rapidly emerging policy challenge: how to generate and interpret credible evidence about the biological capabilities and risks of AI scientists, or agentic AI systems capable of autonomously or collaboratively performing multi-step scientific tasks.
arXiv:2609.23806v1 Announce Type: new Abstract: Many knowledge-work benchmarks are constructed around individual tasks, with the context needed for each task selected together with or after the task...
arXiv:2609.13907v1 Announce Type: cross Abstract: Pharmaceutical sales forecasts inform planning across products, regions, and distribution channels, yet their interpretation depends on inventory ava...
arXiv:2608. 11341v1 Announce Type: new Abstract: Apollo did not reach the Moon merely because its engineers could solve difficult equations.
arXiv:2608. 07627v1 Announce Type: new Abstract: Hospitals are racing to embed AI, while coping with the surge in adaptation of the technology in other industries, into the triage management, documentation, scheduling, and revenue-cycle workflows, yet most deployments remain as fragmented pilots that stall at the edge of production, exposing patients and institutions to operational fragility, ungoverned risk, and mounting technical debt.
arXiv:2606. 19245v1 Announce Type: new Abstract: Artificial intelligence (AI) agents promise to accelerate drug discovery by compressing interpretation and decision-making loops, but practical deployment requires trusted evaluation on realistic program decisions.
arXiv:2608. 08621v1 Announce Type: new Abstract: Running a business is a challenging form of intelligent work.
The paper introduces an LLM-as-a-Judge framework for evaluating the outputs of an agentic drug discovery assistant, ChatInvent, deployed at AstraZeneca. It defines four quality dimensions—Completeness, Relevancy, Structural Clarity, and Scope Adherence—alongside deterministic Tool Call Correctness checks, and validates the judge against five expert annotators. After optimizing the best-performing judge with few-shot demonstrations, alignment with human majority votes improves from 0.80 to 0.86, and the framework reveals that informal question phrasing does not degrade output quality.
arXiv:2602. 19502v2 Announce Type: replace Abstract: Agentic AI systems are increasingly capable of autonomous data science workflows, yet clinical prediction tasks demand domain expertise that purely automated approaches struggle to provide.